Ohtsubo T, Nishioka K, Imaiso Y, Iwai S, Shimokawa H, Oda H, Fujiwara T, Nakabeppu Y
Department of Biochemistry, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.
Nucleic Acids Res. 2000 Mar 15;28(6):1355-64. doi: 10.1093/nar/28.6.1355.
An enzyme activity introducing an alkali-labile site at 2-hydroxyadenine (2-OH-A) in double-stranded oligonucleotides was detected in nuclear extracts of Jurkat cells. This activity co-eluted with activities toward adenine paired with guanine and 8-oxo-7,8-dihydroguanine (8-oxoG) as a single peak corresponding to a 55 kDa molecular mass on gel filtration chromatography. Further co-purification was then done. Western blotting revealed that these activities also co-purified with a 52 kDa polypeptide which reacted with antibodies against human MYH (anti-hMYH). Recombinant hMYH has essentially similar activities to the partially purified enzyme. Thus, hMYH is likely to possess both adenine and 2-OH-A DNA glycosylase activities. In nuclear extracts from Jurkat cells, a 52 kDa polypeptide was detected with a small amount of 53 kDa polypeptide, while in mitochondrial extracts a 57 kDa polypeptide was detected using anti-hMYH. With amplification of the 5'-regions of the hMYH cDNA, 10 forms of hMYH transcripts were identified and subgrouped into three types, each with a unique 5' sequence. These hMYH transcripts are likely to encode multiple authentic hMYH polypeptides including the 52, 53 and 57 kDa polypeptides detected in Jurkat cells.
在Jurkat细胞的核提取物中检测到一种酶活性,该活性可在双链寡核苷酸的2-羟基腺嘌呤(2-OH-A)处引入一个碱不稳定位点。在凝胶过滤色谱中,这种活性与针对与鸟嘌呤配对的腺嘌呤以及8-氧代-7,8-二氢鸟嘌呤(8-oxoG)的活性共同洗脱,形成一个对应于55 kDa分子量的单峰。随后进行了进一步的共纯化。蛋白质印迹分析表明,这些活性也与一种52 kDa的多肽共同纯化,该多肽与抗人MYH(抗hMYH)抗体发生反应。重组hMYH具有与部分纯化的酶基本相似的活性。因此,hMYH可能同时具有腺嘌呤和2-OH-A DNA糖基化酶活性。在Jurkat细胞的核提取物中,检测到一种52 kDa的多肽以及少量53 kDa的多肽,而在线粒体提取物中,使用抗hMYH检测到一种57 kDa的多肽。通过扩增hMYH cDNA的5'区域,鉴定出10种hMYH转录本,并将其分为三种类型,每种类型都有独特的5'序列。这些hMYH转录本可能编码多种真实的hMYH多肽,包括在Jurkat细胞中检测到的52、53和57 kDa的多肽。